Aragen, a global Contract Research, Development and Manufacturing Organization (CRDMO), has made two senior level appointments:

• Dr. Manjunath Ramarao, Chief Scientific Officer (CSO) and Executive Vice President, Integrated Drug Discovery (IDD), based in the USA.
• Jayadeva Sajankila, Vice President and Head, Chemical Development Solutions, based in Hyderabad.

Dr. Manjunath Ramarao

As CSO, Ramarao will provide scientific leadership, nurture scientific talent, identify new and emerging capabilities and technologies and focus on green science initiatives. He will also lead Aragen’s IDD business and will be responsible for formulation and execution of the IDD strategy with P&L responsibility.

Ramarao comes with over 25 years of multidisciplinary experience in the global biopharmaceutical research and development. Prior to joining Aragen, he was the CSO at Atomic AI and Ribometrix Inc in the US. He has also held various leadership positions at Bristol Myers Squibb and Wyeth (Pfizer).

Jayadeva Sajankila

Sajankila joins as the Vice President and Head of Chemical Development Solutions (CDS), one of the largest and critical businesses of Aragen. He will be responsible for driving growth of the CDS business, enhancing operational excellence, and spearheading new technology initiatives to bolster Aragen’s capabilities in small molecules development and manufacturing. He will also oversee client engagement, retention, and growth along with P&L responsibilities for the division.

Sajankila joins Aragen with over 26 years of industry experience in Process R&D, Process Safety, Technology Transfer and Commercialization. Prior to joining Aragen, he was the Head of Project & Portfolio Management, Chemical Development at Syngene International Limited, Bangalore.